Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Cancer Vaccines01:30

Cancer Vaccines

517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ionomic Screening of BRRI dhan84 Mutagenized Population Identifies Candidate Genes Underlying High Arsenic and Low Zinc/Cadmium Accumulation.

Physiologia plantarum·2026
Same author

Dermal Toxicity of Nanoparticles: A Review of Recent Progress.

Chemical research in toxicology·2026
Same author

The emerging role of magnesium in peripheral nerve regeneration: biomaterial design, mechanistic basis, and translational barriers.

Journal of materials chemistry. B·2026
Same author

In-silico target prediction and pathway analysis of propranolol as a potential therapeutic agent for hepatocellular carcinoma.

PloS one·2026
Same author

Isolation and characterization of bacteria degrading sulfur-containing heterocyclic compounds present in desalinated produced water.

Environmental technology·2026
Same author

Unlocking the potential of lipid-based nanoparticles for intranasal drug delivery in Parkinson's disease.

International journal of pharmaceutics·2026
Same journal

Overcoming Immunological Barriers in MSC-Derived Insulin-Producing Cells through CRISPR-Based Hypoimmunogenic Engineering and Translational Perspectives for Type 1 Diabetes.

Stem cell reviews and reports·2026
Same journal

A Letter Matters: ADRB2 rs1042713 c.46A Modulates Anti-osteogenic Effect of Epinephrine in Human Mesenchymal Stem Cells.

Stem cell reviews and reports·2026
Same journal

Targeted Strategies of Adipose Stem Cells for Metabolic Diseases: Mechanisms and Clinical Translation Challenges.

Stem cell reviews and reports·2026
Same journal

Research Progress on Biomaterial Scaffolds Carrying Stem Cells for Inflammation Regulation After Spinal Cord Injury.

Stem cell reviews and reports·2026
Same journal

Dnmt3L Acetylation as a Post-Translational Switch Linking Extracellular Environment to Epigenetic Stability in Pluripotent Stem Cells.

Stem cell reviews and reports·2026
Same journal

Targeting Gli1<sup>+</sup> Cells for Oral Tissue Regeneration and Disease Treatment.

Stem cell reviews and reports·2026
See all related articles

Related Experiment Video

Updated: Sep 16, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

811

Stem Cell for Cancer Immunotherapy: Current Approaches and Challenges.

Zainab Alali1, Umme Tamanna Ferdous2, Alexis Nzila1,3

  • 1Department of Bioengineering, King Fahd University of Petroleum & Minerals, 31261, Dhahran, Saudi Arabia.

Stem Cell Reviews and Reports
|July 12, 2025
PubMed
Summary
This summary is machine-generated.

Stem cell immunotherapy offers novel cancer treatment strategies by engineering immune cells and modifying the tumor microenvironment. Ongoing research addresses challenges to enhance safety and efficacy for personalized cancer therapies.

Keywords:
CAR-T cellsCRISPRCancerImmunotherapyMicroenvironmentStem cells

More Related Videos

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
10:57

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

10.5K
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.0K

Related Experiment Videos

Last Updated: Sep 16, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

811
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
10:57

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

10.5K
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.0K

Area of Science:

  • Oncology
  • Immunology
  • Regenerative Medicine

Background:

  • Stem cell-based immunotherapy is a rapidly advancing field in cancer treatment.
  • It utilizes the immune system to target and eliminate cancer cells.
  • Various stem cell types, including hematopoietic, mesenchymal, and induced pluripotent stem cells (IPSCs), are being explored.

Purpose of the Study:

  • To review stem cell functionalities in cancer immunotherapy.
  • To discuss clinical applications and challenges of stem cell technology in cancer treatment.
  • To highlight advancements and future trends in stem cell-based cancer therapies.

Main Methods:

  • Review of current literature on stem cell applications in cancer immunotherapy.
  • Exploration of stem cell roles in modifying the tumor microenvironment (TME).
  • Analysis of engineered immune cells (CAR-T, NK cells) and drug delivery systems.

Main Results:

  • Stem cells can modify the TME and support engineered immune cells like CAR-T and NK cells.
  • Clinical applications include improved cancer immunotherapies and targeted drug delivery to solid tumors.
  • Challenges include safety, tumor immune evasion, manufacturing, and regulatory hurdles.

Conclusions:

  • Advancements like CRISPR gene editing and targeted delivery systems are overcoming current challenges.
  • Personalized stem cell therapies and combination treatments show promise for increased efficacy.
  • Stem cell immunotherapy holds significant potential for future cancer treatment paradigms.